Karbamid Evolan

Urea 5% Emollient Cream for Dry Skin and Eczema Prevention

OTC – No Prescription Needed ATC: D02AE01 Emollient / Keratolytic
Active Ingredient
Urea (carbamide) 5%
Available Forms
Cream (topical)
Strength
50 mg/g (5%)
Common Brands
Karbolan, Calmuril, Karbamid NET, Curemid
Medically reviewed | Last reviewed: | Evidence level: 1A
Karbamid Evolan is a white emollient cream containing 5% urea (carbamide), a naturally occurring humectant that binds water in the outer layer of the skin. It is used for moisturising treatment of dry skin of various causes and for preventing relapse of atopic eczema (atopic dermatitis). Available over the counter, it is a cornerstone of daily skin care for people with chronically dry or eczema-prone skin.
Published:
Reading time: 10 minutes
Reviewed:

Quick Facts About Karbamid Evolan

Active Ingredient
Urea 5%
(carbamide)
Drug Class
Emollient
Keratolytic / Humectant
ATC Code
D02AE01
Dermatological
Common Uses
Dry Skin
Eczema prevention
Available Form
Cream
Topical application
Prescription Status
OTC
No prescription needed

Key Takeaways About Karbamid Evolan

  • Natural moisturiser: Urea is a naturally occurring component of the skin's own moisturising factor (NMF), making it highly effective and well-tolerated for restoring skin hydration
  • Safe for daily use: At 5% concentration, Karbamid Evolan is gentle enough for daily, long-term use on most body areas including the face, though facial skin may be more sensitive
  • Pregnancy and breastfeeding safe: Can be used safely during pregnancy and while breastfeeding, with minimal systemic absorption from topical application
  • Mild, temporary side effects: The most common side effect is a brief stinging or warming sensation after application, particularly on sensitive or damaged skin
  • Contains potential allergens: The formula includes parabens, cetostearyl alcohol, and propylene glycol which can cause allergic reactions in some individuals

What Is Karbamid Evolan and What Is It Used For?

Karbamid Evolan is a white emollient cream containing 5% urea (carbamide) that works by binding water in the outermost layer of the skin (stratum corneum), thereby normalising hydration in dry skin. It is used for moisturising treatment of dry skin from various causes and for preventing relapse of atopic eczema.

Urea, also known as carbamide, is one of the most well-established and extensively studied moisturising agents in dermatology. It is a naturally occurring substance that forms a key component of the skin's natural moisturising factor (NMF) – a complex mixture of water-soluble compounds within the stratum corneum that help maintain proper skin hydration. In healthy skin, urea typically accounts for approximately 7% of the NMF. When the skin becomes dry, NMF levels decrease, leading to impaired water retention and a compromised skin barrier.

At the 5% concentration found in Karbamid Evolan, urea functions primarily as a humectant – a substance that attracts and retains water molecules. When applied to the skin, the urea molecules penetrate into the stratum corneum and bind water through their hygroscopic properties. This increases the water content of the outer skin layers, resulting in improved hydration, softness, and suppleness. The effect is not merely superficial; urea also enhances the skin's ability to retain moisture over time by helping to restore the natural balance of the NMF.

Karbamid Evolan is indicated for two primary uses. First, it serves as a moisturising treatment for dry skin of various origins. This includes dry skin caused by environmental factors (cold weather, low humidity, frequent hand washing), age-related skin dryness (xerosis), and dry skin associated with various dermatological conditions. Second, it is used for the prevention of atopic eczema relapse. Consistent use of emollients is considered the foundation of atopic dermatitis management according to international guidelines from the British Association of Dermatologists (BAD), the American Academy of Dermatology (AAD), and the European Academy of Dermatology and Venereology (EADV).

Research has demonstrated that regular emollient use in patients with atopic dermatitis significantly reduces the frequency and severity of flare-ups, decreases the need for topical corticosteroids, and improves overall quality of life. A systematic review published in the British Journal of Dermatology (2017) found that emollient therapy reduced the risk of eczema flares by approximately 50% compared to no treatment. The National Institute for Health and Care Excellence (NICE) recommends emollients as first-line therapy that should be continued even when the eczema is clear.

Good to know:

Urea-based creams have been used in dermatology for over 75 years. Urea was first used therapeutically in dermatology in the 1940s. Today, it remains one of the most widely recommended moisturising ingredients by dermatologists worldwide, available in concentrations ranging from 2% to 40% depending on the intended use. The World Health Organization (WHO) includes urea in its Model List of Essential Medicines as a keratolytic agent for dermatological conditions.

What Should You Know Before Using Karbamid Evolan?

Karbamid Evolan is generally very safe and well-tolerated. The main precaution is to avoid applying it to eyes, nose, ears, open wounds, or mucous membranes. It contains excipients (parabens, cetostearyl alcohol, propylene glycol) that may cause allergic reactions in sensitive individuals.

Contraindications

You should not use Karbamid Evolan if you have a known allergy (hypersensitivity) to urea or any of the other ingredients in the cream. The full list of excipients is provided in the ingredients section below. Signs of an allergic reaction may include intense redness, swelling, itching, or a rash at the application site that does not resolve. If you have previously experienced allergic reactions to urea-containing products, consult your doctor or pharmacist before use.

Warnings and Precautions

While Karbamid Evolan has an excellent safety profile for topical use, the following precautions should be observed:

  • Avoid contact with sensitive areas: Do not apply the cream to eyes, nose, ears, open wounds, or mucous membranes. If accidental contact occurs, rinse thoroughly with water
  • Broken or inflamed skin: Applying urea cream to areas of acutely inflamed, broken, or fissured skin may cause a stinging or burning sensation. If your skin is actively inflamed (e.g., during an eczema flare), you may wish to wait until the acute inflammation has subsided before using urea-containing emollients, or use a urea-free emollient during flares
  • Facial skin sensitivity: The face is particularly sensitive to urea-containing products. Some individuals may experience more pronounced stinging or warmth when applying to the face. Consider testing on a small facial area first

Important Information About Certain Excipients

Karbamid Evolan contains several excipients that may cause reactions in sensitive individuals:

  • Ethyl and methyl parahydroxybenzoate (parabens): These preservatives can cause allergic reactions, which may sometimes be delayed (occurring hours to days after application). Paraben allergy is uncommon but well-documented in dermatological literature. If you have a known paraben sensitivity, avoid this product
  • Cetostearyl alcohol: This emulsifying agent can cause local skin reactions such as contact dermatitis in susceptible individuals. Symptoms may include redness, itching, or small blisters at the application site
  • Propylene glycol (50 mg per gram of cream): This humectant can cause skin irritation in some people. Do not use on newborns (younger than 4 weeks) with open wounds or large areas of damaged skin (such as burns) without consulting a doctor or pharmacist. For older children and adults, propylene glycol at this concentration is generally well-tolerated

Pregnancy and Breastfeeding

Karbamid Evolan can be used safely during pregnancy and breastfeeding. Urea is a naturally occurring substance in the human body, and the 5% concentration in this cream results in minimal systemic absorption when applied to intact skin. There are no known risks to the developing foetus or nursing infant from topical urea application at this concentration.

Many pregnant women experience increased skin dryness, particularly in the third trimester, due to hormonal changes and increased skin stretching. Emollient therapy with urea-containing products is widely recommended by obstetric and dermatological guidelines for managing pregnancy-related dry skin. If you have any concerns, discuss emollient options with your midwife or doctor.

Driving and Operating Machinery

Karbamid Evolan has no effect on the ability to drive or use machines. As a topical emollient, it does not enter the systemic circulation in meaningful quantities and has no known effects on cognitive function, reflexes, or alertness.

How Does Karbamid Evolan Interact with Other Drugs?

Karbamid Evolan has no known clinically significant drug interactions when used as directed. However, because urea can mildly enhance the penetration of other topical products, it is advisable to allow adequate time between applying this cream and other topical medications.

One of the advantages of Karbamid Evolan is its excellent safety profile regarding drug interactions. Because urea at 5% concentration is applied topically and has minimal systemic absorption, it does not interact with oral medications, injections, or other systemic treatments. You can safely use Karbamid Evolan while taking other medications by mouth or injection.

Topical Product Interactions

While not technically drug interactions in the pharmacological sense, there are some practical considerations when using Karbamid Evolan alongside other topical products:

  • Topical corticosteroids: Urea can enhance the penetration of other topical agents through the skin. If you are using topical corticosteroids (e.g., hydrocortisone, betamethasone) for eczema treatment, apply the corticosteroid first and wait at least 15–30 minutes before applying Karbamid Evolan. This timing is recommended by the BAD and NICE guidelines to prevent enhanced corticosteroid absorption
  • Topical calcineurin inhibitors: If using tacrolimus (Protopic) or pimecrolimus (Elidel), follow the same spacing recommendation. Apply the calcineurin inhibitor first, wait 15–30 minutes, then apply the emollient
  • Other emollients and moisturisers: There is generally no issue with combining Karbamid Evolan with other moisturising products, although using multiple emollients simultaneously is usually unnecessary
  • Sunscreens: Apply Karbamid Evolan first, allow it to absorb fully, and then apply sunscreen on top. This sequence helps ensure that the sunscreen forms an effective protective film on the skin surface
Recommended Timing Between Topical Products and Karbamid Evolan
Product Apply Order Wait Time Notes
Topical corticosteroids Corticosteroid first 15–30 minutes Prevents enhanced corticosteroid absorption
Calcineurin inhibitors Calcineurin inhibitor first 15–30 minutes As per BAD/NICE guidelines
Sunscreen Emollient first 10–15 minutes Ensures sunscreen film integrity
Topical antibiotics Antibiotic first 15–30 minutes Allow medication to absorb first
Topical retinoids Retinoid first 20–30 minutes Retinoids on dry skin; emollient after
Clinical tip:

The "soak and seal" technique is recommended by dermatologists for maximum moisturising benefit. After bathing or showering, gently pat the skin until slightly damp (not fully dry), then immediately apply Karbamid Evolan. This helps trap the moisture from bathing within the skin and maximises the hydrating effect of the urea.

What Is the Correct Dosage of Karbamid Evolan?

For dry skin, apply Karbamid Evolan as needed, preferably several times daily and always after contact with water. For atopic eczema prevention, apply at least twice daily. Use enough cream for the skin to absorb without feeling greasy.

Karbamid Evolan is a topical cream and should always be used exactly as described in the patient information leaflet or as directed by a doctor, pharmacist, or nurse. Unlike many systemic medications, emollient dosing is flexible and should be guided by the degree of skin dryness and the body area being treated.

For Dry Skin of Various Causes

General Dry Skin Treatment

Apply the cream as needed, preferably several times daily and always after contact with water (hand washing, bathing, showering, swimming). Apply a sufficient amount for the skin to absorb without leaving a greasy residue. The exact quantity will depend on the body area and the degree of dryness.

Dermatological guidelines generally recommend that adults with widespread dry skin use approximately 250–500 grams of emollient per week for whole-body application. This translates to applying emollient liberally and frequently throughout the day. Many patients under-use emollients, applying too little or too infrequently to achieve optimal results. The key principle is to use enough emollient to keep the skin hydrated throughout the entire day.

For Prevention of Atopic Eczema Relapse

Eczema Prevention Regimen

Apply the cream at least twice daily, and preferably after every contact with water. Consistent daily use is essential for maintaining the skin barrier and preventing eczema flare-ups, even when the skin appears clear and symptom-free.

The BAD and NICE guidelines emphasise that emollient therapy should be continued as a daily routine even during periods when the eczema is well-controlled and the skin appears normal. Stopping emollient use when symptoms improve is one of the most common reasons for eczema relapse. Regular emollient application helps maintain the skin barrier, reduces transepidermal water loss, and decreases the likelihood of flare-ups.

Recommended Application by Patient Group
Patient Group Indication Frequency Special Notes
Adults Dry skin Several times daily + after water contact 250–500 g per week for whole-body use
Adults Eczema prevention At least twice daily + after water contact Continue even when skin is clear
Children (>4 weeks) Dry skin / eczema As for adults Safe; use less cream on smaller areas
Elderly Age-related dryness Several times daily Particularly important for lower legs
Pregnant women Pregnancy-related dryness As needed, several times daily Safe throughout pregnancy

Correct Application Technique

For best results, follow these application guidelines:

  1. Wash your hands before applying the cream (unless treating the hands)
  2. Apply in the direction of hair growth using smooth, downward strokes rather than rubbing vigorously. This reduces the risk of folliculitis (inflammation of hair follicles)
  3. Use enough cream so the skin feels comfortably moisturised but not excessively greasy. As a rough guide, one "fingertip unit" (the amount from the tip to the first crease of an adult index finger) covers an area approximately twice the size of an adult hand
  4. Allow the cream to absorb for a few minutes before dressing or applying other products
  5. Apply after bathing while the skin is still slightly damp to lock in additional moisture

Missed Application

If you forget to apply Karbamid Evolan at your usual time, simply apply it as soon as you remember. There is no risk of "overdosing" with a topical emollient, and you cannot use too much. Do not skip the next application – return to your regular routine. Consistent, frequent application yields the best results for skin hydration and eczema prevention.

Overdose

Topical overdose with Karbamid Evolan is not considered a clinical concern. Urea at 5% concentration does not cause toxicity when applied to the skin, even in large amounts. If the cream is accidentally ingested, it is unlikely to cause harm in small quantities, but seek medical advice if a significant amount has been swallowed, particularly by a child.

What Are the Side Effects of Karbamid Evolan?

Karbamid Evolan is very well-tolerated. The most common side effect is a temporary, mild stinging or warming sensation at the application site, which occurs in more than 1 in 100 users. Facial skin is particularly sensitive to this effect. Serious side effects are extremely rare.

Like all medicines, Karbamid Evolan can cause side effects, but not everybody gets them. The side effect profile of topical urea at 5% concentration is very favourable compared to many other dermatological treatments. Most side effects are mild, localised, and transient, typically resolving within minutes of application.

The stinging or warming sensation that some users experience is not an allergic reaction but rather a normal physiological response that occurs when urea interacts with nerve endings in the skin. This effect is more pronounced on skin that is very dry, cracked, or damaged, and tends to decrease over time as the skin barrier improves with regular emollient use. The face, particularly the cheeks and around the eyes, is more sensitive to this effect due to the thinner skin in these areas.

Common

Affects more than 1 in 100 users
  • Transient local stinging or burning sensation at the application site
  • Temporary warmth or heat sensation at the application site
  • Mild redness at the site of application (usually resolves within 30 minutes)

Uncommon

Affects less than 1 in 100 users
  • Skin irritation or itching at the application site
  • Contact dermatitis due to excipients (parabens, cetostearyl alcohol, propylene glycol)
  • Dryness or peeling at the application site (paradoxical reaction)

Rare

Affects less than 1 in 1,000 users
  • Allergic contact dermatitis (delayed hypersensitivity to parabens or other excipients)
  • Urticaria (hives) at or near the application site

When to Seek Medical Advice

Most side effects of Karbamid Evolan are mild and do not require medical attention. However, you should stop using the cream and consult a healthcare professional if you experience any of the following:

  • Persistent redness, swelling, or itching that worsens after each application (may indicate an allergic reaction to an excipient)
  • Blistering or weeping of the skin at the application site
  • Severe burning that does not subside within a few minutes
  • Signs of a generalised allergic reaction (widespread rash, difficulty breathing, facial swelling) – these are extremely rare but require immediate medical attention

If you suspect that Karbamid Evolan is causing an allergic reaction, it is important to identify which specific ingredient is responsible. Your doctor or dermatologist can perform patch testing to determine whether you are allergic to urea itself or to one of the excipients (most commonly parabens or cetostearyl alcohol). This information helps in selecting alternative emollient products that do not contain the offending ingredient.

Reporting side effects:

It is important to report suspected side effects after a medicine has been authorised. This makes it possible to continuously monitor the benefit-risk balance of the medicine. Healthcare professionals and patients are encouraged to report any suspected adverse reactions to their national pharmacovigilance authority (e.g., the EMA in Europe, the FDA in the United States, or the MHRA in the United Kingdom).

How Should You Store Karbamid Evolan?

Store Karbamid Evolan at or below 25°C (77°F). Keep out of sight and reach of children. Do not use after the expiry date printed on the packaging.

Proper storage is important to maintain the effectiveness and safety of Karbamid Evolan throughout its shelf life. Urea-containing creams are generally stable formulations, but exposure to excessive heat or inappropriate storage conditions can affect the consistency, efficacy, and safety of the product.

Storage Conditions

  • Temperature: Store at or below 25°C (77°F). Avoid storing in hot environments such as near radiators, in direct sunlight, or in a car during warm weather
  • Away from children: Keep the cream out of the sight and reach of children at all times
  • Expiry date: Do not use the cream after the expiry date printed on the packaging. The expiry date refers to the last day of the stated month
  • After opening: Once opened, use within the recommended period (typically stated on the packaging). Close the cap or pump firmly after each use to prevent contamination and drying out

Proper Disposal

Do not dispose of Karbamid Evolan in household waste or down the drain. Return any unused or expired cream to your local pharmacy for safe disposal. This helps protect the environment and ensures that expired medications are not accidentally used.

What Does Karbamid Evolan Contain?

The active ingredient is urea (carbamide) at a concentration of 50 mg/g (5%). The cream also contains several excipients including medium-chain triglycerides, polysorbate 60, cetostearyl alcohol, propylene glycol, and parabens as preservatives.

Active Ingredient

Each gram of Karbamid Evolan contains 50 mg of urea (carbamide), equivalent to a 5% concentration. Urea is a small organic molecule (molecular formula: CO(NH₂)₂) with a molecular weight of 60.06 g/mol. It is highly water-soluble and colourless, making it an ideal ingredient for white, cosmetically elegant cream formulations.

Excipients (Inactive Ingredients)

The remaining ingredients serve various functions in the cream formulation, including providing the cream base, maintaining stability, preserving against microbial contamination, and adjusting the pH:

Complete List of Excipients
Ingredient Function Notes
Medium-chain triglycerides Emollient base Provides the oily phase of the cream
Polysorbate 60 Emulsifier Helps oil and water phases mix
Cetostearyl alcohol Emulsifier / thickener May cause contact dermatitis in rare cases
Hydrogenated rapeseed oil Emollient Skin-softening agent
Propylene glycol (E 1520) Humectant / solvent 50 mg/g; may cause skin irritation
Carbomer Thickening agent Provides cream consistency
Dimethicone Skin protectant Forms a protective barrier on the skin
Hard paraffin Occlusive agent Helps prevent water loss from the skin
Glycerol polymethacrylate Film-forming agent Improves skin feel
Ethylparaben (E 214) Preservative May cause allergic reactions (possibly delayed)
Methylparaben (E 218) Preservative May cause allergic reactions (possibly delayed)
Sodium lactate solution pH adjuster / humectant Natural component of skin NMF
Citric acid pH adjuster Maintains optimal cream pH
Stearoyl macrogol glycerides Emulsifier Stabilises the cream formulation
Purified water Solvent / vehicle Forms the aqueous phase of the cream

Packaging and Appearance

Karbamid Evolan is a white cream available in the following packaging sizes:

  • 100 g tube: Aluminium-laminated plastic tube (polyethylene) with a snap-on cap, suitable for travel and targeted application
  • 500 g pump dispenser: Plastic container (polypropylene) with pump, ideal for daily whole-body use
  • 600 g combination pack: Contains one 500 g pump dispenser plus one 100 g tube, offering both convenience and portability

Not all pack sizes may be available in all markets. The larger pump dispenser format is particularly practical for patients who require frequent, generous application as part of their daily eczema management routine.

Frequently Asked Questions About Karbamid Evolan

Karbamid Evolan is a moisturising cream containing 5% urea, used for treating dry skin of various causes and for preventing relapse of atopic eczema (atopic dermatitis). Urea is a natural component of the skin's own moisturising system and works by binding water in the outer layer of the skin, helping to restore normal hydration levels. It is available over the counter and suitable for daily long-term use.

Yes, Karbamid Evolan can be used safely during pregnancy and breastfeeding. Urea is a naturally occurring substance in the body, and the 5% concentration in this cream results in minimal systemic absorption when applied topically. There are no known risks to the developing baby or nursing infant. Many pregnant women find emollient therapy especially helpful as hormonal changes can increase skin dryness.

The most common side effect is a transient local stinging or warming sensation after application, which affects more than 1 in 100 users. The face is particularly sensitive to this effect. These sensations are temporary and usually subside within minutes. The cream also contains parabens, cetostearyl alcohol, and propylene glycol, which may rarely cause allergic reactions or contact dermatitis in sensitive individuals.

For general dry skin treatment, apply as needed, preferably several times daily and always after contact with water (such as after washing hands or showering). Apply enough cream for the skin to absorb without feeling greasy. For preventing atopic eczema relapse, apply at least twice daily, and preferably after every contact with water. Consistent daily use is essential, even when the skin appears healthy.

Urea creams are available in various concentrations ranging from 2% to 40% or higher. Low concentrations (2–10%, such as Karbamid Evolan at 5%) primarily act as moisturisers and are suitable for daily maintenance of dry skin. Medium concentrations (10–20%) provide stronger moisturising effects and mild keratolytic (softening) action. High concentrations (20–40%) are used for thickened, very dry, or scaly skin conditions and have significant keratolytic properties. The appropriate strength depends on the severity of dryness and the body area being treated.

Yes, Karbamid Evolan can be applied to the face, but be aware that facial skin is particularly sensitive and may experience a stronger stinging or warming sensation compared to other body areas. Avoid applying the cream near the eyes, nose, or mouth. If you experience persistent irritation on facial skin, consider using a lower-concentration urea product or consult your dermatologist for alternative recommendations.

References and Sources

  1. Pan M, Heinecke G, Bernardo S, Tsui C, Levitt J. Urea: a comprehensive review of the clinical literature. Dermatology Online Journal. 2013;19(11):20392. DOI: 10.5070/D31911020392
  2. Lodén M. The clinical benefit of moisturizers. Journal of the European Academy of Dermatology and Venereology. 2005;19(6):672–688. DOI: 10.1111/j.1468-3083.2005.01326.x
  3. Van Zuuren EJ, Fedorowicz Z, Christensen R, Lavrijsen A, Arents BWM. Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews. 2017;2(2):CD012119. DOI: 10.1002/14651858.CD012119.pub2
  4. National Institute for Health and Care Excellence (NICE). Eczema – atopic: Management. Clinical Knowledge Summaries (CKS). Last revised February 2024.
  5. Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema. Journal of the European Academy of Dermatology and Venereology. 2022;36(8):1409–1431. DOI: 10.1111/jdv.18345
  6. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: Section 2. Management and treatment of atopic dermatitis with topical therapies. Journal of the American Academy of Dermatology. 2014;71(1):116–132. DOI: 10.1016/j.jaad.2014.03.023
  7. British Association of Dermatologists (BAD). Patient information leaflet: Emollients. Updated 2024.
  8. World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. 2023.
  9. Rawlings AV, Canestrari DA, Dobkowski B. Moisturizer technology versus clinical performance. Dermatologic Therapy. 2004;17(Suppl 1):49–56. DOI: 10.1111/j.1396-0296.2004.04S1006.x
  10. European Medicines Agency (EMA). Annex to the European Commission guideline on 'Excipients in the labelling and package leaflet of medicinal products for human use.' EMA/CHMP/302620/2017. Revised 2024.

Editorial Team

This article has been written and reviewed by the iMedic Medical Editorial Team, consisting of licensed physicians specialising in dermatology, clinical pharmacology, and general practice.

Medical Content Written by specialist physicians with expertise in dermatology and emollient therapy, based on international guidelines and peer-reviewed literature.
Medical Review Reviewed by the iMedic Medical Review Board according to BAD, NICE, AAD, and EuroGuiDerm guidelines. Evidence Level: 1A.
Accessibility Verified WCAG 2.2 Level AAA compliance with screen readers, keyboard navigation, and assistive technologies.
Last Updated Content last reviewed and updated on . Next scheduled review: July 2026.

Conflict of interest declaration: The iMedic editorial team has no financial relationships with pharmaceutical companies. All content is independently produced with no commercial funding or sponsorship.